Startpagina>Klinisch wetenschappelijk onderzoek>Klinische studies>RPE65-NHS

How to use the speech recognition tool?



Natural history of patients with inherited retinal diseases due to mutations in RPE65 gene

Type: Observational

Status of the trial: Active, Not recruiting

Orphan Drug Recognition: NA


  • Opening Date: 2020-05-01
  • Closing Date: 0000-00-00


Inclusion: subjects diagnosed with retinitis pigmentosa or Leber congenital amaurosis

Exclusion: participation in a clinical study with an investigational drug during the retrospective study time period (i.e., from 01/01/1990 to study start date)

More information

Children: Yes

Adults: Yes

Funder Type: other

Within ERN-EYE members


  • Retinal Rare Eye Diseases (WG1)

Subscribe to our mailing list

* indicates required

This ERN is supported by: